Dr. Reddy’s Laboratories Ltd. ADR (NYSE:RDY) does about 776.61K shares in volume on a normal day but saw 1587198 shares change hands in the recent trading day. The company now has a market cap of 11.76B USD. Its current market price is $14.10, marking a decrease of -0.49% compared to the previous close of $14.17. The 52 week high reached by this stock is $16.89 whilst the lowest price level in 52 weeks is $12.90.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) has a 20-day trading average at $14.96 and the current price is -16.53% off the 52-week high compared with 9.30% distance from its 52-week low. The 50-day simple moving average of the closing price is $15.48 and its 200-day simple moving average is $15.19. If we look at the stock’s price movements over the week, volatility stands at 1.71%, which increases to 1.84% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 29.52 to suggest the stock is oversold.
The consensus objective for the share price is $16.17, suggesting that the stock has a potential upside of 12.8% over the period.
The current price level is -5.73%, -8.91%, and -7.20% away from its SMA20, SMA50, and SMA200 respectively, with the RDY price moving above the 50-day SMA on current market day. Dr. Reddy’s Laboratories Ltd. ADR (RDY) stock is down -6.00% over the week and -11.51% over the past month. Its price is 1.32% year-to-date and 6.22% over the past year.
To reach the target analysts have set, the stock logically needs to grow 12.8 percent from here.
Outstanding shares total 834.09M with insiders holding 0.00% of the shares and institutional holders owning 2.85% of the company’s common stock. The company has a return on investment of 17.14% and return on equity of 19.12%. The price to earnings ratio (P/E ratio) amounts to 18.38 while the forward price to earnings ratio is 17.26. The beta has a value of 0.55. Price to book ratio is 3.23 and price to sales ratio is 3.27.
